News

Quotient Sciences wins multiple categories in 2021 CRO Leadership Awards

Quotient has been recognized with multiple 2021 CRO Leadership Awards, including two Champion Awards.  The CRO Leadership Awards recognizes top performing outsourcing organizations in the drug development arena. Quotient received leadership awards in five of the overall six categories. The categories included: Capabilities, Compatibility, Expertise, Reliability, Quality and Phase IV, each further divided into three groups – Big Pharma, Small Pharma, and Overall. Quotient was also honored with two champion awards. Champion awards are given to companies that score 11/2 standard deviation more above the weighted average in each of the categories and are deemed “top performers”.

Champion Award Winning Categories:

  • Expertise (Overall)
  • Quality (Overall)

Leadership Award Winning Categories:

  • Capabilities (Overall, Small Pharma)
  • Compatibility (Overall, Small Pharma)
  • Expertise (Overall, Small Pharma)
  • Reliability (Overall, Small Pharma)
  • Quality (Overall, Small Pharma) 

The 2021 CRO Leadership Awards Clinical Leader and Life Science Leader teamed up with Industry Standard Research (ISR) to determine the award recipients. 60 contract research organizations were assessed on 20+ performance metrics in ISR’s annual CRO Quality Benchmarking survey.  Survey participants were recruited from pharma and biopharma companies of all sizes and were screened for decision-making influence related to working with contract research organizations. Respondents only evaluate companies with which they have worked on an outsourced project within the past 18 months. This level of qualification ensures that survey responses are based on actual involvement with CROs and clear experiential data.

For more information about the CRO Leadership Awards click here.

We use cookies to help us to improve our site and enables us to the best possible service and customer experience. By clicking accept you are agreeing to let us share your data with select third parties for analytics and marketing purposes.